Related Experiment Video
Updated: Jun 2, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
Dermatofibrosarcoma Protuberans, Version 1.2025, NCCN Clinical Practice Guidelines In Oncology
Jeremy Bordeaux1, Rachel Blitzblau2, Sumaira Z Aasi3
1Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
Abstract:
Dermatofibrosarcoma protuberans (DFSP) is a rare cutaneous soft tissue sarcoma and affects an estimated 1,500 people annually in the United States. DFSP frequently exhibits extensive local infiltration. Initial treatment is through surgical excision, and care should be taken to ensure that negative margins are achieved to minimize recurrence. Although DFSP has a reported high rate of recurrence, metastasis is more uncommon. Fibrosarcomatous DFSP is an aggressive variant with an increased risk for local recurrence and metastasis. If achieving negative margins or resection is not feasible, radiation therapy or systemic treatment are options that may be considered by a multidisciplinary team. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) outline recommended treatment options available for DFSP.
Insights
Dermatofibrosarcoma protuberans (DFSP) is a rare skin cancer. Surgical excision with negative margins is key to minimizing recurrence, though other treatments exist for difficult cases.
Area of Science:
- Oncology
- Dermatology
- Surgical Pathology
Background:
- Dermatofibrosarcoma protuberans (DFSP) is a rare malignant neoplasm of the skin.
- DFSP is characterized by extensive local infiltration and a high rate of recurrence.
- Metastasis is uncommon, but the fibrosarcomatous variant presents an increased risk.
Purpose of the Study:
- To summarize the key aspects of Dermatofibrosarcoma protuberans (DFSP).
- To highlight the importance of surgical margins in DFSP treatment.
- To outline alternative treatment modalities for unresectable or recurrent DFSP.
Main Methods:
- Review of existing literature on Dermatofibrosarcoma protuberans.
- Analysis of treatment strategies including surgical excision, radiation therapy, and systemic treatments.
- Reference to the NCCN Clinical Practice Guidelines for Oncology.
Main Results:
- Surgical excision with negative margins is the primary treatment for DFSP.
- Achieving negative margins is crucial for minimizing local recurrence.
- Radiation therapy and systemic treatments are viable options when complete resection is not feasible.
Conclusions:
- Dermatofibrosarcoma protuberans requires careful surgical management to prevent recurrence.
- Aggressive variants like fibrosarcomatous DFSP necessitate prompt and potentially multimodal treatment.
- Adherence to established guidelines, such as the NCCN Guidelines, ensures optimal patient care.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Targeted Cancer Therapies
There are several types of targeted therapies against...

